tradmap

BOLD Earnings Boundless Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$41 -$20 $0 2023 2024 2025
EPS
Net income (annual)
-$65M -$33M $0 2023 2024 2025
Net income
Return on equity (annual)
-59% -10% 39% 0% 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$31 -$15 $0 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26
EPS
Net income (quarterly)
-$17M -$8M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income
Return on equity (quarterly)
-16% -2% 11% 0% Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
ROE

Reported EPS history

1–14 of 14
Q2 20262026-06-30-1.662026-08-0710-Q
Q1 20262026-03-31-0.602026-05-0810-Q
FY 20252025-12-31-2.602026-03-0910-K
Q3 20252025-09-30-2.032025-11-0510-Q
Q2 20262025-06-30-1.412026-08-0710-Q
Q1 20262025-03-31-0.712026-05-0810-Q
FY 20252024-12-31-3.852026-03-0910-K
Q3 20252024-09-30-3.222025-11-0510-Q
Q2 20252024-06-30-2.782025-08-0510-Q
Q1 20252024-03-31-12.272025-05-0910-Q
FY 20242023-12-31-40.652025-03-2710-K
Q3 20242023-09-30-30.892024-11-0710-Q
Q2 20242023-06-30-20.182024-08-1210-Q
Q1 20242023-03-31-9.912024-05-1310-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.